Actionable insights — Friday POW!: Vistra Corp (VST)

1. Separate a hedge-accounting distortion from an operating problem — and check whether the distortion's cause is itself a strength

1. When a company with a forward-selling business model (power generators, miners, airlines, commodity processors, insurers) misses on a reported line, ask first whether the miss sits in unrealised mark-to-market on contracts that have not settled. Those swings are revaluations of promises, not cash.
2. State the distinction in both directions so you cannot be accused of hand-waving: the number is real in the GAAP sense and irrelevant in the economic sense. GAAP is correctly reporting a revaluation; the revaluation is not information about the business.
3. Find the undistorted line in the same release and use it instead. Segment or generation-level EBITDA, volumes, and physical utilisation sit below the mark-to-market layer.
4. Now run the step most analysts skip: ask what created the distortion. If the answer is a hedging program, the same program is delivering earnings certainty — the optical cost and the fundamental benefit are the same fact. That converts an apparent negative into a positive without any new information.
5. Quantify the certainty: get the hedge coverage percentage by year. Near-100% coverage in the current year means the reported guidance is close to arithmetic; declining coverage in outer years is where the real risk (and the unhedged upside) lives.
6. Confirm the losses actually reverse: unrealised marks on a hedge that will be physically delivered into settle out over the contract's life. If instead the hedge is speculative or the underlying may not be produced, the loss is real and this method does not apply.

• The quarters in which those marks reverse into realised results — the direct test that the losses were timing rather than economics. And the opposite tell: a hedge book whose losses keep growing while realised margins do not improve, which means the hedges are mispriced rather than mistimed.

2. Value the company on guidance that excludes its own announced catalysts — the "not in the numbers" gap

1. Read the guidance footnotes and exclusions before the guidance itself. Management routinely omits pending acquisitions, unsigned or not-yet-effective contracts, new ventures and pending tax credits, because accounting conservatism forbids including them until they close.
2. List each exclusion with its size, mechanism and timing — the acquisition's price and megawatts, the contract's capacity and effective date, the venture's committed capital. Vague optionality is not an exclusion; a signed, dated, sized item is.
3. Size each one's earnings contribution separately and be explicit about the assumption used (a comparable multiple on the purchase price, a per-unit margin on contracted volume). Show the range, not a point.
4. Build the forward base by adding them to the guided midpoint at their expected effective dates, then state the resulting outer-year number as a single figure you can be judged on.
5. Compare that base to the current market capitalisation and ask the diagnostic question: is any of it in the price? A multiple struck on excluding guidance is, by construction, the most conservative multiple available.
6. The whole method only works when the exclusions are announced and contractual. Applying it to pipeline, ambitions or "TAM" is how the same reasoning becomes a trap.

• The close of the acquisition and the first guidance revision that includes it — the moment the gap starts converting into reported numbers, and the most likely re-rating catalyst. Conversely, a slipped closing date or a contract whose effective date keeps moving turns the gap from conservatism into wishful thinking.

3. Underwrite a demand thesis on observed data, not forward projections

1. For any thesis that depends on a demand boom, ask what would count as evidence it is already happening — as opposed to evidence that people expect it to happen. Order books, forecasts and capex announcements are the latter.
2. Find the industry's real-time operational series: grid peak load for power, throughput for pipelines and ports, utilisation for fabs and fleets, occupancy for property. These are published, high-frequency, and cannot be talked up.
3. Prefer a series that sets a record — a new all-time high in a physically-constrained metric is unambiguous in a way a growth rate is not.
4. Pair the demand series with a supply-side series the company controls (availability, uptime, capacity factor). Record demand plus proven delivery is the pair that gets paid; record demand alone might accrue to someone else.
5. Say explicitly which projection you are declining to rely on, so the thesis is not quietly resting on it anyway.

• Next summer's peak-load prints in both grids, and the gap between peak load growth and new generation interconnected. A record load met comfortably by new supply is a very different investment than a record load met by the incumbent fleet running flat out.

4. Test whether a thesis is evolving or breaking — relocate the moat when the original one is regulated away

1. When a credible bear piece appears, concede its correct premise explicitly and in its own terms. Refusing the concession costs credibility and, more practically, prevents you from finding out what survives it.
2. Name the mechanism the bear is attacking. Here it is scarcity rents: the excess price an owner of scarce capacity extracts when demand outruns supply — the leg regulators can and do cap.
3. Ask what the regulation cannot change. Physical lead times, permits already granted, interconnections already built, and existing customer relationships are not policy variables.
4. Restate the thesis in the new terms as a before-and-after sentence. If you can write "the market is shifting from X to Y" and the company still wins under Y, the thesis evolved. If you cannot, it broke — and the honest move is to say so.
5. Check whether the regulatory response creates a substitute revenue channel. Rules that cap merchant pricing frequently push value into bilateral contracts, uprates and brownfield expansion — which favour incumbents with existing sites.
6. Verify the company is already moving that way, using announced initiatives as evidence. A thesis evolution that management has not begun executing is your own hypothesis, not theirs.

• The share of earnings arriving through bilateral contracts and new-build capacity versus merchant market pricing. A rising contracted share is the thesis evolving on schedule; a flat one with capped merchant prices is the thesis quietly breaking while the narrative holds.

5. Read who is partnering with the asset owner as an independent signal of scarcity

1. When a venture is announced, ignore the press release framing and ask what each partner is contributing and what each one lacks. The lack is the information.
2. A structure in which capital, technology and a sovereign mandate all assemble around one physical asset tells you that asset is the binding constraint — otherwise the money would have gone straight to building a substitute.
3. Distinguish a partnership from an offtake contract. A PPA buys output at a price; a capital-committing platform makes the generator a developer with an equity interest in future capacity — a different and larger claim on the opportunity.
4. Weigh the committed capital against the company's own size to gauge how much of the thesis is execution risk versus already-earned position.
5. Check whether the venture's economics are in guidance. If they are not, this insight compounds with the "not in the numbers" method above rather than duplicating it.

• The first announced Helix project and its contracted capacity — the proof the platform converts capital into committed megawatts. Also watch it as a risk: it is "capital subject to milestones and execution risk in an unfamiliar infrastructure-development business," which is exactly how a stated advantage becomes a stated bear leg.

6. Use free-cash-flow yield on a normalised base as the entry metric — and show the conversion assumption

1. For a capital-intensive business, prefer FCF yield to an earnings multiple as the entry metric: it nets out the maintenance capex that an EBITDA multiple hides.
2. Compute the current-year yield first off guided FCF and today's market cap — that is the return if nothing improves, and it is the floor of the argument.
3. Then compute the normalised yield: take management's own stated EBITDA-to-FCF conversion target, apply it to the outer-year EBITDA base built from the excluded catalysts, and divide by today's capitalisation. Using today's cap is the point — it states the return on the price you can pay now.
4. Say the conversion rate out loud ("over 60% of adjusted EBITDA to FCF") so the reader can substitute their own and see how sensitive the answer is.
5. Cross-check the yield against the EV/EBITDA multiple and against a close comparable — two independent measures pointing the same way is what makes the discount credible.
6. Treat the sell-side target as a sentiment reading rather than a valuation, and quote the count of analysts behind it.

• Whether reported FCF conversion actually tracks the >60% target as growth capex rises — a company spending into a build-out often converts far less, which would cut the normalised yield well before the EBITDA base disappoints.

7. Bound a bear case by requiring every leg to hit — then say what would make you wrong

1. Enumerate the bear case as discrete named risks and concede each is "credible to some degree." A bear case you have not stated cleanly is one you have not tested.
2. Ask whether the current price is only justified if all of them occur, or whether one alone suffices. If all three are required, the price is being set off a joint probability materially lower than any single leg.
3. Express the conclusion as a threshold claim — "we think that threshold is too high" — rather than a forecast; it survives being early and does not require predicting outcomes.
4. Check independence before relying on the argument. Legs driven by the same underlying cause are not separate risks, and the joint-probability framing quietly fails.
5. Handle the category risk (the one that invalidates the whole sector, not just the name) separately and quantitatively: not "will it happen" but "how much slower, and does the thesis survive that rate?"
6. Do not let the argument absolve the technical picture. State the chart honestly even when it disagrees with the fundamentals, and attach a mechanical exit so the position does not depend on re-arguing the thesis under stress.

• Two of the three legs landing together — at that point the joint-probability defence is gone and the position rests on the last one. And, mechanically, a break of 130: the stop is the pre-committed answer to the thesis being wrong for a reason not on the list.